COST

1,048.96

+0.89%↑

80.84

+0.46%↑

141.6

-0.8%↓

189.84

-1.05%↓

PEP

149.1

+0.33%↑

COST

1,048.96

+0.89%↑

80.84

+0.46%↑

141.6

-0.8%↓

189.84

-1.05%↓

PEP

149.1

+0.33%↑

COST

1,048.96

+0.89%↑

80.84

+0.46%↑

141.6

-0.8%↓

189.84

-1.05%↓

PEP

149.1

+0.33%↑

COST

1,048.96

+0.89%↑

80.84

+0.46%↑

141.6

-0.8%↓

189.84

-1.05%↓

PEP

149.1

+0.33%↑

COST

1,048.96

+0.89%↑

80.84

+0.46%↑

141.6

-0.8%↓

189.84

-1.05%↓

PEP

149.1

+0.33%↑

Home・Aktien・Lifecore Biomedical Inc

Lifecore Biomedical Inc

Geschlossen

BrancheKonsumgüter defensiv

4.38 -3.74

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

4.38

Max

4.42

Schlüsselkennzahlen
By Trading Economics
Einkommen	3.9M -6M
Verkäufe	-5.3M 31M
Gewinnspanne	-19.435
Angestellte	382

Empfehlungen
By TipRanks
Empfehlungen	Starkes Kaufsignal
12-Monats-Prognose	+51.59% upside

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-92M 149M
Vorheriger Eröffnungskurs	8.12
Vorheriger Schlusskurs	4.38

Nachrichtenstimmung

By Acuity

50%

53 / 131 Ranking in Consumer defensive

Lifecore Biomedical Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

17. Mai 2026, 23:53 UTC

Akquisitionen, Fusionen, Übernahmen

Prudential PLC to Buy Majority Stake in India Life Insurer for $389 Million

15. Mai 2026, 22:47 UTC

Heiße Aktien

Stocks to Watch: Macy's, Delta, UnitedHealth, NextNRG

15. Mai 2026, 22:16 UTC

Akquisitionen, Fusionen, Übernahmen

Canadian Tribunal Gives Keyera, Plains Until Late June to Rebut Bid to Undo Merger

15. Mai 2026, 22:00 UTC

Wichtige Markttreiber

Delta Air Shares Rise as Berkshire Hathaway Discloses Stake

15. Mai 2026, 18:09 UTC

Wichtige Markttreiber

Palo Alto Shares Head for Record-High Close, Analysts See Benefits to Identity Security Pivot

17. Mai 2026, 23:50 UTC

Market Talk

Gold Consolidates; May be Weighed by Fed Rate-Hike Expectations -- Market Talk

17. Mai 2026, 23:43 UTC

Market Talk

Global Equities Roundup: Market Talk

17. Mai 2026, 23:43 UTC

Market Talk

Nikkei May Decline Amid Middle East Uncertainty -- Market Talk

17. Mai 2026, 23:36 UTC

Market Talk

Oil Rises Amid Prospects of Prolonged Strait of Hormuz Closure -- Market Talk

17. Mai 2026, 23:07 UTC

Akquisitionen, Fusionen, Übernahmen

UOB: Transactions Part of Group's Capital Reallocation Strategy

17. Mai 2026, 23:06 UTC

Akquisitionen, Fusionen, Übernahmen

UOB: Share Sale Agreements Entered With Singland Properties

17. Mai 2026, 23:05 UTC

Akquisitionen, Fusionen, Übernahmen

UOB: Divestments' Aggregate Consideration of S$299M in Cash

17. Mai 2026, 22:31 UTC

Akquisitionen, Fusionen, Übernahmen

Prudential PLC to Fund Stake Acquisition via Internal Resources

17. Mai 2026, 22:31 UTC

Akquisitionen, Fusionen, Übernahmen

Prudential PLC to Acquire Stake for $389 Million

17. Mai 2026, 22:30 UTC

Akquisitionen, Fusionen, Übernahmen

Prudential PLC to Acquire 75% Stake in Bharti Life Insurance

16. Mai 2026, 16:27 UTC

Akquisitionen, Fusionen, Übernahmen

NextEra Is In Talks to Buy Dominion, Report Says. What a Deal Could Mean. -- Barrons.com

16. Mai 2026, 15:26 UTC

Akquisitionen, Fusionen, Übernahmen

NextEra Energy Near Deal for Rival Utility Dominion -- WSJ

16. Mai 2026, 08:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

15. Mai 2026, 22:17 UTC

Akquisitionen, Fusionen, Übernahmen

Berkshire Boosted Stake in Alphabet in First Quarter, Bought Delta Air, Sold Visa, Mastercard -- Barrons.com

15. Mai 2026, 21:59 UTC

Akquisitionen, Fusionen, Übernahmen

Stanley Druckenmiller Just Exited Alphabet. TCI Fund Management Is Buying. -- Barrons.com

15. Mai 2026, 21:50 UTC

Akquisitionen, Fusionen, Übernahmen

Berkshire Boosted Stake in Alphabet in First Quarter, Bought Delta Air, Sold Visa, Mastercard -- Barrons.com

15. Mai 2026, 21:30 UTC

Akquisitionen, Fusionen, Übernahmen

Bill Ackman's Pershing Square Bets on Microsoft's AI Ambitions With New Stake -- 4th Update

15. Mai 2026, 21:16 UTC

Market Talk

Canada Oil Producers Expect Govt Cash Before Building Pathways Project -- Market Talk

15. Mai 2026, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

15. Mai 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

15. Mai 2026, 20:19 UTC

Heiße Aktien

Stocks to Watch Recap: Intel, Nvidia, Amgen, LVMH -- WSJ

15. Mai 2026, 19:41 UTC

Akquisitionen, Fusionen, Übernahmen

SanDisk Stock Is Up 494% This Year. Insiders Are Cashing In on the AI-Fueled Surge. -- Barrons.com

15. Mai 2026, 19:35 UTC

Market Talk

Oil Futures Settle Higher on Inventory Worries -- Market Talk

15. Mai 2026, 19:33 UTC

Market Talk

U.S. Natural Gas Futures Rise as Weather Heats Up -- Market Talk

15. Mai 2026, 18:35 UTC

Ergebnisse

Xanadu Quantum Revenue Increases Fourfold. Why the Stock Is Falling. -- Barrons.com

Peer-Vergleich

Kursveränderung

Lifecore Biomedical Inc Prognose

Kursziel

By TipRanks

51.59% Vorteil

12-Monats-Prognose

Durchschnitt 6.67 USD 51.59%

Hoch 9 USD

Tief 5 USD

Basierend auf 4 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Lifecore Biomedical Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

4 ratings

Buy

Halten

Sell

Basierend auf 4 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Lifecore Biomedical Inc – Dist abgegeben haben.

Stimmung

By Acuity

53 / 131 Ranking in Konsumgüter defensiv

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Lifecore Biomedical Inc

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.